Invenomic Capital Management »

Tandem Diabetes Care shares owned by Invenomic Capital Management

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by Invenomic Capital Management from 13F filings

Historical chart of Invenomic Capital Management investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by Invenomic Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by Invenomic Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.1M 241k 29.58
2023-09-30 $5.7M 272k 20.77
2023-06-30 $2.0M 82k 24.54

More positions owned by Invenomic Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Us Home Cons Etf Put Option (ITB)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Viatris (VTRS)
Ss&c Technologies Holding (SSNC)
Illumina (ILMN)
Clarivate Ord Shs (CLVT)
Chord Energy Corporation Com New (CHRD)
Solaredge Technologies (SEDG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Zoom Video Communications In Cl A (ZM)
At&t (T)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Wright Express (WEX)
Quidel Corp (QDEL)

View all positions for Invenomic Capital Management

Top funds holding Tandem Diabetes Care

Vanguard Group
Arrowpoint Asset Management
Henderson Group
Jennison Associates
Bellevue Group
Jacobs Levy Equity Management
Jennifer Ranahan
Paradice Investment Management
Two Sigma Advisers
Point72 Asset Management
Voloridge Investment Management
Two Sigma Investments
Chicago Capital
Millennium Management
Squarepoint Ops

View all funds holding Tandem Diabetes Care